Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden
Abstract Background A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden. Methods We ident...
Saved in:
Published in | European journal of cancer (1990) Vol. 49; no. 12; pp. 2705 - 2716 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
2013
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Background A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden. Methods We identified 27,235 patients from the Swedish Melanoma Register diagnosed with a primary invasive CMM between 1990 and 2007 and linked data to nationwide, population-based, health and census registers with a follow-up to 2010. Results The odds ratio (OR) of higher disease stage at diagnosis was significantly increased in lower education groups (OR stage II versus I = 1.6; 95% confidence interval (CI) = 1.5–1.7. OR stage III–IV versus I = 2.3; 95% CI = 1.8–2.9). The risk of dying of CMM, was significantly increased in patients with low (hazard ratio (HR) low versus high = 2.02; 95% CI = 1.80–2.26; p < 0.0001) and intermediate (HR intermediate versus high = 1.35; 95% CI = 1.20–1.51; p < 0.0001) level of education. After adjustment for age, gender, stage at diagnosis and other known prognostic factors, the HRs remained significant for low versus high (HR = 1.13; 95% CI = 1.01–1.27; p = 0.04) but not for intermediate versus high (HR = 1.11; 95% CI = 0.99–1.24; p = 0.08) education. The HR associated with low level of education was significantly higher among female patients, patients <55 years, patients with truncal tumours and during the first 5 years after diagnosis. Conclusion Lower level of education is associated with reduced CMM-specific survival, which may at least partially be attributed to a more advanced stage at diagnosis. These results emphasise the need for improved early detection strategies. |
---|---|
AbstractList | A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden.
We identified 27,235 patients from the Swedish Melanoma Register diagnosed with a primary invasive CMM between 1990 and 2007 and linked data to nationwide, population-based, health and census registers with a follow-up to 2010.
The odds ratio (OR) of higher disease stage at diagnosis was significantly increased in lower education groups (OR stage II versus I=1.6; 95% confidence interval (CI)=1.5-1.7. OR stage III-IV versus I=2.3; 95% CI=1.8-2.9). The risk of dying of CMM, was significantly increased in patients with low (hazard ratio (HR) low versus high=2.02; 95% CI=1.80-2.26; p<0.0001) and intermediate (HR intermediate versus high=1.35; 95% CI=1.20-1.51; p<0.0001) level of education. After adjustment for age, gender, stage at diagnosis and other known prognostic factors, the HRs remained significant for low versus high (HR=1.13; 95% CI=1.01-1.27; p=0.04) but not for intermediate versus high (HR=1.11; 95% CI=0.99-1.24; p=0.08) education. The HR associated with low level of education was significantly higher among female patients, patients <55 years, patients with truncal tumours and during the first 5 years after diagnosis.
Lower level of education is associated with reduced CMM-specific survival, which may at least partially be attributed to a more advanced stage at diagnosis. These results emphasise the need for improved early detection strategies. BACKGROUNDA worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden.METHODSWe identified 27,235 patients from the Swedish Melanoma Register diagnosed with a primary invasive CMM between 1990 and 2007 and linked data to nationwide, population-based, health and census registers with a follow-up to 2010.RESULTSThe odds ratio (OR) of higher disease stage at diagnosis was significantly increased in lower education groups (OR stage II versus I=1.6; 95% confidence interval (CI)=1.5-1.7. OR stage III-IV versus I=2.3; 95% CI=1.8-2.9). The risk of dying of CMM, was significantly increased in patients with low (hazard ratio (HR) low versus high=2.02; 95% CI=1.80-2.26; p<0.0001) and intermediate (HR intermediate versus high=1.35; 95% CI=1.20-1.51; p<0.0001) level of education. After adjustment for age, gender, stage at diagnosis and other known prognostic factors, the HRs remained significant for low versus high (HR=1.13; 95% CI=1.01-1.27; p=0.04) but not for intermediate versus high (HR=1.11; 95% CI=0.99-1.24; p=0.08) education. The HR associated with low level of education was significantly higher among female patients, patients <55 years, patients with truncal tumours and during the first 5 years after diagnosis.CONCLUSIONLower level of education is associated with reduced CMM-specific survival, which may at least partially be attributed to a more advanced stage at diagnosis. These results emphasise the need for improved early detection strategies. A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden. We identified 27,235 patients from the Swedish Melanoma Register diagnosed with a primary invasive CMM between 1990 and 2007 and linked data to nationwide, population-based, health and census registers with a follow-up to 2010. The odds ratio (OR) of higher disease stage at diagnosis was significantly increased in lower education groups (OR stage II versus I=1.6; 95% confidence interval (CI)=1.5–1.7. OR stage III–IV versus I=2.3; 95% CI=1.8–2.9). The risk of dying of CMM, was significantly increased in patients with low (hazard ratio (HR) low versus high=2.02; 95% CI=1.80–2.26; p<0.0001) and intermediate (HR intermediate versus high=1.35; 95% CI=1.20–1.51; p<0.0001) level of education. After adjustment for age, gender, stage at diagnosis and other known prognostic factors, the HRs remained significant for low versus high (HR=1.13; 95% CI=1.01–1.27; p=0.04) but not for intermediate versus high (HR=1.11; 95% CI=0.99–1.24; p=0.08) education. The HR associated with low level of education was significantly higher among female patients, patients <55years, patients with truncal tumours and during the first 5years after diagnosis. Lower level of education is associated with reduced CMM-specific survival, which may at least partially be attributed to a more advanced stage at diagnosis. These results emphasise the need for improved early detection strategies. Background: A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden. Methods: We identified 27,235 patients from the Swedish Melanoma Register diagnosed with a primary invasive CMM between 1990 and 2007 and linked data to nationwide, population-based, health and census registers with a follow-up to 2010. Results: The odds ratio (OR) of higher disease stage at diagnosis was significantly increased in lower education groups (OR stage II versus I = 1.6; 95% confidence interval (CI) = 1.5-1.7. OR stage III-IV versus I = 2.3; 95% CI = 1.8-2.9). The risk of dying of CMM, was significantly increased in patients with low (hazard ratio (HR) low versus high = 2.02; 95% CI = 1.80-2.26; p < 0.0001) and intermediate (HR intermediate versus high = 1.35; 95% CI = 1.20-1.51; p < 0.0001) level of education. After adjustment for age, gender, stage at diagnosis and other known prognostic factors, the HRs remained significant for low versus high (HR = 1.13; 95% CI = 1.01-1.27; p = 0.04) but not for intermediate versus high (HR = 1.11; 95% CI = 0.99-1.24; p = 0.08) education. The HR associated with low level of education was significantly higher among female patients, patients <55 years, patients with truncal tumours and during the first 5 years after diagnosis. Conclusion: Lower level of education is associated with reduced CMM-specific survival, which may at least partially be attributed to a more advanced stage at diagnosis. These results emphasise the need for improved early detection strategies. BACKGROUND: A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden. METHODS: We identified 27,235 patients from the Swedish Melanoma Register diagnosed with a primary invasive CMM between 1990 and 2007 and linked data to nationwide, population-based, health and census registers with a follow-up to 2010. RESULTS: The odds ratio (OR) of higher disease stage at diagnosis was significantly increased in lower education groups (OR stage II versus I=1.6; 95% confidence interval (CI)=1.5-1.7. OR stage III-IV versus I=2.3; 95% CI=1.8-2.9). The risk of dying of CMM, was significantly increased in patients with low (hazard ratio (HR) low versus high=2.02; 95% CI=1.80-2.26; p<0.0001) and intermediate (HR intermediate versus high=1.35; 95% CI=1.20-1.51; p<0.0001) level of education. After adjustment for age, gender, stage at diagnosis and other known prognostic factors, the HRs remained significant for low versus high (HR=1.13; 95% CI=1.01-1.27; p=0.04) but not for intermediate versus high (HR=1.11; 95% CI=0.99-1.24; p=0.08) education. The HR associated with low level of education was significantly higher among female patients, patients <55years, patients with truncal tumours and during the first 5years after diagnosis. CONCLUSION: Lower level of education is associated with reduced CMM-specific survival, which may at least partially be attributed to a more advanced stage at diagnosis. These results emphasise the need for improved early detection strategies. Abstract Background A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden. Methods We identified 27,235 patients from the Swedish Melanoma Register diagnosed with a primary invasive CMM between 1990 and 2007 and linked data to nationwide, population-based, health and census registers with a follow-up to 2010. Results The odds ratio (OR) of higher disease stage at diagnosis was significantly increased in lower education groups (OR stage II versus I = 1.6; 95% confidence interval (CI) = 1.5–1.7. OR stage III–IV versus I = 2.3; 95% CI = 1.8–2.9). The risk of dying of CMM, was significantly increased in patients with low (hazard ratio (HR) low versus high = 2.02; 95% CI = 1.80–2.26; p < 0.0001) and intermediate (HR intermediate versus high = 1.35; 95% CI = 1.20–1.51; p < 0.0001) level of education. After adjustment for age, gender, stage at diagnosis and other known prognostic factors, the HRs remained significant for low versus high (HR = 1.13; 95% CI = 1.01–1.27; p = 0.04) but not for intermediate versus high (HR = 1.11; 95% CI = 0.99–1.24; p = 0.08) education. The HR associated with low level of education was significantly higher among female patients, patients <55 years, patients with truncal tumours and during the first 5 years after diagnosis. Conclusion Lower level of education is associated with reduced CMM-specific survival, which may at least partially be attributed to a more advanced stage at diagnosis. These results emphasise the need for improved early detection strategies. Background: A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden. Methods: We identified 27,235 patients from the Swedish Melanoma Register diagnosed with a primary invasive CMM between 1990 and 2007 and linked data to nationwide, population-based, health and census registers with a follow-up to 2010. Results: The odds ratio (OR) of higher disease stage at diagnosis was significantly increased in lower education groups (OR stage II versus I = 1.6; 95% confidence interval (CI) = 1.5-1.7. OR stage III-IV versus I = 2.3; 95% CI = 1.8-2.9). The risk of dying of CMM, was significantly increased in patients with low (hazard ratio (HR) low versus high = 2.02; 95% CI = 1.80-2.26; p < 0.0001) and intermediate (HR intermediate versus high = 1.35; 95% CI = 1.20-1.51; p < 0.0001) level of education. After adjustment for age, gender, stage at diagnosis and other known prognostic factors, the HRs remained significant for low versus high (HR = 1.13; 95% CI = 1.01-1.27; p = 0.04) but not for intermediate versus high (HR = 1.11; 95% CI = 0.99-1.24; p = 0.08) education. The HR associated with low level of education was significantly higher among female patients, patients <55 years, patients with truncal tumours and during the first 5 years after diagnosis. Conclusion: Lower level of education is associated with reduced CMM-specific survival, which may at least partially be attributed to a more advanced stage at diagnosis. These results emphasise the need for improved early detection strategies. (C) 2013 Elsevier Ltd. All rights reserved. BACKGROUND: A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between level of education, clinical stage at diagnosis (stage at diagnosis) and CMM-specific survival in Sweden. METHODS: We identified 27,235 patients from the Swedish Melanoma Register diagnosed with a primary invasive CMM between 1990 and 2007 and linked data to nationwide, population-based, health and census registers with a follow-up to 2010. RESULTS: The odds ratio (OR) of higher disease stage at diagnosis was significantly increased in lower education groups (OR stage II versus I=1.6; 95% confidence interval (CI)=1.5-1.7. OR stage III-IV versus I=2.3; 95% CI=1.8-2.9). The risk of dying of CMM, was significantly increased in patients with low (hazard ratio (HR) low versus high=2.02; 95% CI=1.80-2.26; p<0.0001) and intermediate (HR intermediate versus high=1.35; 95% CI=1.20-1.51; p<0.0001) level of education. After adjustment for age, gender, stage at diagnosis and other known prognostic factors, the HRs remained significant for low versus high (HR=1.13; 95% CI=1.01-1.27; p=0.04) but not for intermediate versus high (HR=1.11; 95% CI=0.99-1.24; p=0.08) education. The HR associated with low level of education was significantly higher among female patients, patients <55years, patients with truncal tumours and during the first 5years after diagnosis. CONCLUSION: Lower level of education is associated with reduced CMM-specific survival, which may at least partially be attributed to a more advanced stage at diagnosis. These results emphasise the need for improved early detection strategies. |
Author | Månsson-Brahme, E Lyth, J Frohm-Nilsson, M Lindholm, C Ingvar, C Eriksson, H Wagenius, G Naredi, P Carstensen, J Hansson, J Stierner, U |
Author_xml | – sequence: 1 fullname: Eriksson, H – sequence: 2 fullname: Lyth, J – sequence: 3 fullname: Månsson-Brahme, E – sequence: 4 fullname: Frohm-Nilsson, M – sequence: 5 fullname: Ingvar, C – sequence: 6 fullname: Lindholm, C – sequence: 7 fullname: Naredi, P – sequence: 8 fullname: Stierner, U – sequence: 9 fullname: Wagenius, G – sequence: 10 fullname: Carstensen, J – sequence: 11 fullname: Hansson, J |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27553480$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23583439$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-95938$$DView record from Swedish Publication Index https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-76655$$DView record from Swedish Publication Index https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-204837$$DView record from Swedish Publication Index https://lup.lub.lu.se/record/3975504$$DView record from Swedish Publication Index http://kipublications.ki.se/Default.aspx?queryparsed=id:126921342$$DView record from Swedish Publication Index |
BookMark | eNqNk1uL1DAYhousuAf9A15IbgQv7Jg0SZuKCMN6hAEvVr0NafJ1zGwmGZtmhv1D_k7TndldEFYWEpqG532_HN6cFkc-eCiK5wTPCCb1m9UMVlrNKkzoDOdG6KPihIimLbHg1VFxglvelgKz9rg4jXGFMW4Ew0-K44pyQRltT4o_i7BDDrbgUOgRmKTVaINHNiIVY9BWjWDQzo6_kMvDAcVRLQGpERmrlj7ECfQGDZM0kzENW7tVDlmPdBqVh5AiWitnl175Ea3BKR_W6i2aI39damcNoE3YJHf9W3YqTj5jMleTycUODPinxeNeuQjPDt-z4senj9_Pv5SLb5-_ns8XpW5wO5ZCV5TmnWGjNRWibYno-7Y2wDFjwI2oWjHNk4oT3fUCuroRjeqAqYZwTOlZUe594w42qZObwa7VcCWDsvIwdZlHIDnNx80y397Lb4Zg7kQ3QlLVbZWlVdYu7tW6tMm9y33SsB5q1tFOUmWwZJhxKXrBpCZdT01faVbrbPf6XrsP9udchmEpU5IVZoI2D8TXSTZ1zfnDcGeTzJHLN3BWvNrj-RB-J4ijXNuowbl9ICShbYs5JwxntNqjeggxDtDfehMsp5zLlZxyLqecS5wbme7pxcE_dWswt5KbYGfg5QFQUSvXD8prG--4Ju-Jian6uz0HOVVbC4OM2oLPUbYD6FGaYP-_jvf_yLWz3uaKl3AFcRXS4HNeJZGxklheTC9yepCEYlyRmtO_UIU2uw |
CitedBy_id | crossref_primary_10_1093_eurpub_ckv112 crossref_primary_10_1016_j_ad_2024_05_013 crossref_primary_10_2340_actadv_v103_4403 crossref_primary_10_1038_bjc_2015_449 crossref_primary_10_1111_ijd_16618 crossref_primary_10_1016_j_canep_2019_101576 crossref_primary_10_3390_cancers13174385 crossref_primary_10_1080_0284186X_2022_2143278 crossref_primary_10_1002_ijc_33803 crossref_primary_10_1111_pcmr_12868 crossref_primary_10_1016_j_ejca_2016_02_029 crossref_primary_10_1186_s12889_019_6667_7 crossref_primary_10_1016_j_jpainsymman_2014_03_004 crossref_primary_10_1177_10732748211011956 crossref_primary_10_1177_1084822315593075 crossref_primary_10_1111_jdv_12471 crossref_primary_10_1002_ijc_31951 crossref_primary_10_1002_ijc_30103 crossref_primary_10_1186_s12955_018_1047_z crossref_primary_10_1111_ddg_15421 crossref_primary_10_1080_0284186X_2019_1566772 crossref_primary_10_1177_23743735211033126 crossref_primary_10_1111_joim_12303 crossref_primary_10_1007_s10552_023_01780_1 crossref_primary_10_1016_j_ejca_2015_07_039 crossref_primary_10_3399_bjgp18X697901 crossref_primary_10_1111_bjd_13483 crossref_primary_10_1007_s11764_020_00859_x crossref_primary_10_1002_ijc_29961 crossref_primary_10_1016_j_sste_2016_05_005 crossref_primary_10_1097_CMR_0000000000000104 crossref_primary_10_1016_j_puhe_2022_06_006 crossref_primary_10_1111_phpp_12139 crossref_primary_10_1684_ejd_2019_3524 crossref_primary_10_1002_lary_30832 crossref_primary_10_1155_2021_9989824 crossref_primary_10_3390_ijerph192214916 crossref_primary_10_1111_bjd_12800 crossref_primary_10_1016_j_ad_2024_02_027 crossref_primary_10_1002_ijc_30843 crossref_primary_10_14423_SMJ_0000000000000888 crossref_primary_10_9778_cmajo_20180089 crossref_primary_10_1177_1203475420960426 crossref_primary_10_1002_ijc_30407 crossref_primary_10_1002_ijc_30925 crossref_primary_10_1136_jech_2016_208706 crossref_primary_10_1200_JCO_2013_52_7564 crossref_primary_10_1371_journal_pone_0252021 crossref_primary_10_1111_ddg_15421_g crossref_primary_10_1111_bjd_13500 crossref_primary_10_1111_jdv_13110 |
Cites_doi | 10.1111/j.1365-2133.2007.07805.x 10.1016/0277-9536(84)90207-7 10.1038/sj.bjc.6605949 10.1002/ijc.25996 10.1016/j.ejca.2010.12.013 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G 10.1056/NEJMoa1103782 10.1136/bmj.312.7039.1125 10.1002/cncr.26707 10.1200/JCO.2001.19.16.3622 10.1002/cncr.26706 10.2105/AJPH.86.4.538 10.1111/j.1365-2133.2010.09977.x 10.1016/j.ejca.2008.06.016 10.1038/jid.2008.423 10.1002/cncr.20602 10.1038/sj.bjc.6603216 10.1016/j.amepre.2008.03.026 10.1002/ijc.25540 10.1093/annonc/mdr128 10.1136/thx.2009.125914 10.1200/JCO.2011.38.0584 10.1001/archdermatol.2009.42 10.1056/NEJMoa1003466 10.1245/s10434-011-1706-3 10.1200/JCO.2001.19.16.3635 10.1093/annonc/mdm413 10.1200/JCO.2005.21.360 10.1111/j.1532-5415.2006.00943.x 10.1080/01621459.1958.10501452 10.4065/mcp.2010.0671 10.1056/NEJMoa1112302 10.1016/j.jaad.2011.05.035 10.1007/s10654-009-9350-y 10.1002/1097-0215(20000520)89:3<271::AID-IJC10>3.0.CO;2-7 |
ContentType | Journal Article |
Copyright | Elsevier Ltd 2013 Elsevier Ltd 2014 INIST-CNRS Copyright © 2013 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: Elsevier Ltd – notice: 2013 Elsevier Ltd – notice: 2014 INIST-CNRS – notice: Copyright © 2013 Elsevier Ltd. All rights reserved. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 ADTPV AOWAS DG8 D93 DF2 D95 |
DOI | 10.1016/j.ejca.2013.03.013 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic SwePub SwePub Articles SWEPUB Linköpings universitet SWEPUB Umeå universitet SWEPUB Uppsala universitet SWEPUB Lunds universitet |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-0852 |
EndPage | 2716 |
ExternalDocumentID | oai_swepub_ki_se_530134 oai_prod_swepub_kib_ki_se_126921342 oai_lup_lub_lu_se_4fe64b3b_3ad0_4045_8f84_c1bf3df2c46c oai_DiVA_org_uu_204837 oai_DiVA_org_umu_76655 oai_DiVA_org_liu_95938 10_1016_j_ejca_2013_03_013 23583439 27553480 S0959804913002165 1_s2_0_S0959804913002165 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Sweden Europe |
GeographicLocations_xml | – name: Sweden |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29G 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAWTL AAXKI AAXUO ABBQC ABFNM ABGSF ABJNI ABLJU ABMAC ABMZM ABOCM ABUDA ABXDB ACDAQ ACIUM ACPRK ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AENEX AEVXI AFCTW AFFNX AFJKZ AFKWA AFRAH AFRHN AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W K-O KOM M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K UV1 WUQ X7M XPP Z5R ZGI ZXP ~G- AAIAV ABLVK ABYKQ AHPSJ AJBFU DOVZS EFLBG LCYCR ZA5 08R AALMO ABFLS ABPIF ABPTK ADALY ADGIM IPNFZ IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 ADTPV AOWAS DG8 D93 DF2 D95 |
ID | FETCH-LOGICAL-c709t-8c2338340dcc3889918ff96de5044e5d829838891251cbf8eb6787abe4a715033 |
IEDL.DBID | AIKHN |
ISSN | 0959-8049 1879-0852 |
IngestDate | Thu Oct 31 04:29:54 EDT 2024 Wed Oct 30 04:41:19 EDT 2024 Thu Oct 31 04:20:01 EDT 2024 Thu Oct 31 04:30:24 EDT 2024 Thu Oct 31 04:44:37 EDT 2024 Thu Oct 31 04:26:01 EDT 2024 Fri Oct 25 02:22:10 EDT 2024 Thu Sep 26 16:24:44 EDT 2024 Sat Sep 28 08:02:04 EDT 2024 Fri Nov 25 13:52:49 EST 2022 Fri Feb 23 02:22:40 EST 2024 Tue Oct 15 23:02:38 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Level of education Population-based Socioeconomic status Stage at diagnosis Survival Melanoma Human Skin disease Malignant tumor Skin cancer Clinical stage Association Cancerology Education Malignant melanoma Diagnosis Cancer |
Language | English |
License | CC BY 4.0 Copyright © 2013 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c709t-8c2338340dcc3889918ff96de5044e5d829838891251cbf8eb6787abe4a715033 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 23583439 |
PQID | 1399055140 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | swepub_primary_oai_swepub_ki_se_530134 swepub_primary_oai_prod_swepub_kib_ki_se_126921342 swepub_primary_oai_lup_lub_lu_se_4fe64b3b_3ad0_4045_8f84_c1bf3df2c46c swepub_primary_oai_DiVA_org_uu_204837 swepub_primary_oai_DiVA_org_umu_76655 swepub_primary_oai_DiVA_org_liu_95938 proquest_miscellaneous_1399055140 crossref_primary_10_1016_j_ejca_2013_03_013 pubmed_primary_23583439 pascalfrancis_primary_27553480 elsevier_sciencedirect_doi_10_1016_j_ejca_2013_03_013 elsevier_clinicalkeyesjournals_1_s2_0_S0959804913002165 |
PublicationCentury | 2000 |
PublicationDate | 2013 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – year: 2013 text: 2013 |
PublicationDecade | 2010 |
PublicationPlace | Kidlington |
PublicationPlace_xml | – name: Kidlington – name: England |
PublicationTitle | European journal of cancer (1990) |
PublicationTitleAlternate | Eur J Cancer |
PublicationYear | 2013 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Hansson (b0230) 2005; 13 Joosse, Collette, Suciu (b0155) 2012; 30 Swetter, Layton, Johnson, Brooks, Miller, Geller (b0160) 2009; 145 Cormier, Xing, Ding (b0190) 2005; 23 Chapman, Hauschild, Robert (b0210) 2011; 364 Kaplan, Meier (b0130) 1958; 53 </csr/1975_2009_pops09/>, based on November 2011 SEER data submission, posted to the SEER web site, April 2012. [accessed March 03, 2013]. Chang, Karnell, Menck (b0075) 1998; 83 Balch, Buzaid, Soong (b0115) 2001; 19 Youl, Baade, Parekh, English, Elwood, Aitken (b0140) 2011; 128 Ludvigsson, Otterblad-Olausson, Pettersson, Ekbom (b0090) 2009; 24 The Swedish Education System. The Swedish National Agency for Education. Available from Swetter, Pollitt, Johnson, Brooks, Geller (b0165) 2012; 118 Nationellt kvalitetsregister för hudmelanom. Diagnosår 1990–2008. In Swedish. Avaiable from Hodi, O’Day, McDermott (b0205) 2010; 363 Linos, Swetter, Cockburn, Colditz, Clarke (b0055) 2009; 129 Berglund, Holmberg, Tishelman, Wagenius, Eaker, Lambe (b0195) 2010; 65 Boyle, O’Hagan, Donnelly (b0170) 2010; 163 Richard, Grob, Avril (b0180) 2000; 89 Louwman, Aarts, Houterman, van Lenthe, Coebergh, Janssen-Heijnen (b0220) 2010; 103 Jemal, Saraiya, Patel (b0020) 2011; 65 Population and Housing Census 1960–1990. Statistics Sweden. Available from Geller, Miller, Lew, Clapp, Wenneker, Koh (b0085) 1996; 86 MacKie, Hole (b0080) 1996; 312 Balch, Soong, Gershenwald (b0175) 2001; 19 Pollitt, Swetter, Johnson, Patil, Geller (b0245) 2012; 118 Baumert, Plewig, Volkenandt, Schmid-Wendtner (b0145) 2007; 156 Pollitt, Clarke, Shema, Swetter (b0135) 2008; 35 Birch-Johansen, Hvilsom, Kjaer, Storm (b0040) 2008; 44 Collins, Fields, Baptiste, Liu, Moley, Jeffe (b0185) 2011; 18 Sosman, Kim, Schuchter (b0215) 2012; 366 Lindholm, Andersson, Dufmats (b0095) 2004; 101 (In Swedish). [accessed March 03, 2013]. Longitudinal integration database for health insurance and labour market studies (LISA by Swedish acronym). Statistics Sweden. Available from Cavalli-Björkman, Lambe, Eaker, Sandin, Glimelius (b0200) 2011; 47 Baade, Meng, Youlden, Aitken, Youl (b0030) 2012; 130 [accessed March 03, 2013]. Ferlay JSH, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from Downing, Newton-Bishop, Forman (b0060) 2006; 95 Hollestein, van den Akker, Nijsten, Karim-Kos, Coebergh, de Vries (b0240) 2012; 23 Reyes-Ortiz, Goodwin, Freeman, Kuo (b0065) 2006; 54 Kogevinas MPN, Susser M, Boffetta P. Social inequalities and cancer. IARC Scientific Publications No. 138; ed. Lyon: International Agency for Research on Cancer; 1997. Vagero, Persson (b0035) 1984; 19 Mandala, Imberti, Piazzalunga (b0050) 2011; 86 Hussain, Lenner, Sundquist, Hemminki (b0070) 2008; 19 Howlader NNA, Krapcho M, Neyman N, et al., editors. SEER cancer statistics review, 1975–2009 (Vintage 2009 populations). Bethesda, MD: National Cancer Institute. Available from Singh, Ajani, Johnson (b0045) 2011; 65 Lindholm (10.1016/j.ejca.2013.03.013_b0095) 2004; 101 Kaplan (10.1016/j.ejca.2013.03.013_b0130) 1958; 53 10.1016/j.ejca.2013.03.013_b0005 Louwman (10.1016/j.ejca.2013.03.013_b0220) 2010; 103 10.1016/j.ejca.2013.03.013_b0105 Hodi (10.1016/j.ejca.2013.03.013_b0205) 2010; 363 10.1016/j.ejca.2013.03.013_b0125 Hussain (10.1016/j.ejca.2013.03.013_b0070) 2008; 19 Ludvigsson (10.1016/j.ejca.2013.03.013_b0090) 2009; 24 Pollitt (10.1016/j.ejca.2013.03.013_b0245) 2012; 118 Swetter (10.1016/j.ejca.2013.03.013_b0160) 2009; 145 Hansson (10.1016/j.ejca.2013.03.013_b0230) 2005; 13 Chapman (10.1016/j.ejca.2013.03.013_b0210) 2011; 364 Jemal (10.1016/j.ejca.2013.03.013_b0020) 2011; 65 Cavalli-Björkman (10.1016/j.ejca.2013.03.013_b0200) 2011; 47 Vagero (10.1016/j.ejca.2013.03.013_b0035) 1984; 19 Reyes-Ortiz (10.1016/j.ejca.2013.03.013_b0065) 2006; 54 Sosman (10.1016/j.ejca.2013.03.013_b0215) 2012; 366 Joosse (10.1016/j.ejca.2013.03.013_b0155) 2012; 30 Boyle (10.1016/j.ejca.2013.03.013_b0170) 2010; 163 Hollestein (10.1016/j.ejca.2013.03.013_b0240) 2012; 23 10.1016/j.ejca.2013.03.013_b0120 Singh (10.1016/j.ejca.2013.03.013_b0045) 2011; 65 Youl (10.1016/j.ejca.2013.03.013_b0140) 2011; 128 MacKie (10.1016/j.ejca.2013.03.013_b0080) 1996; 312 Linos (10.1016/j.ejca.2013.03.013_b0055) 2009; 129 10.1016/j.ejca.2013.03.013_b0015 Balch (10.1016/j.ejca.2013.03.013_b0175) 2001; 19 Geller (10.1016/j.ejca.2013.03.013_b0085) 1996; 86 Cormier (10.1016/j.ejca.2013.03.013_b0190) 2005; 23 Baumert (10.1016/j.ejca.2013.03.013_b0145) 2007; 156 Chang (10.1016/j.ejca.2013.03.013_b0075) 1998; 83 Birch-Johansen (10.1016/j.ejca.2013.03.013_b0040) 2008; 44 Downing (10.1016/j.ejca.2013.03.013_b0060) 2006; 95 Collins (10.1016/j.ejca.2013.03.013_b0185) 2011; 18 Berglund (10.1016/j.ejca.2013.03.013_b0195) 2010; 65 Richard (10.1016/j.ejca.2013.03.013_b0180) 2000; 89 Mandala (10.1016/j.ejca.2013.03.013_b0050) 2011; 86 Balch (10.1016/j.ejca.2013.03.013_b0115) 2001; 19 10.1016/j.ejca.2013.03.013_b0010 10.1016/j.ejca.2013.03.013_b0110 Baade (10.1016/j.ejca.2013.03.013_b0030) 2012; 130 Pollitt (10.1016/j.ejca.2013.03.013_b0135) 2008; 35 Swetter (10.1016/j.ejca.2013.03.013_b0165) 2012; 118 |
References_xml | – volume: 23 start-page: 524 year: 2012 end-page: 530 ident: b0240 article-title: Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates publication-title: Ann Oncol contributor: fullname: de Vries – volume: 130 start-page: 170 year: 2012 end-page: 178 ident: b0030 article-title: Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990–2006 publication-title: Int J Cancer contributor: fullname: Youl – volume: 44 start-page: 2043 year: 2008 end-page: 2049 ident: b0040 article-title: Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994–2003 publication-title: Eur J Cancer contributor: fullname: Storm – volume: 95 start-page: 91 year: 2006 end-page: 95 ident: b0060 article-title: Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993–2003 publication-title: Br J Cancer contributor: fullname: Forman – volume: 129 start-page: 1666 year: 2009 end-page: 1674 ident: b0055 article-title: Increasing burden of melanoma in the United States publication-title: J Invest Dermatol contributor: fullname: Clarke – volume: 86 start-page: 538 year: 1996 end-page: 543 ident: b0085 article-title: Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts publication-title: Am J Public Health contributor: fullname: Koh – volume: 18 start-page: 2925 year: 2011 end-page: 2936 ident: b0185 article-title: Racial differences in survival after surgical treatment for melanoma publication-title: Ann Surg Oncol contributor: fullname: Jeffe – volume: 103 start-page: 1742 year: 2010 end-page: 1748 ident: b0220 article-title: A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status publication-title: Br J Cancer contributor: fullname: Janssen-Heijnen – volume: 35 start-page: 7 year: 2008 end-page: 13 ident: b0135 article-title: California Medicaid enrollment and melanoma stage at diagnosis: a population-based study publication-title: Am J Prev Med contributor: fullname: Swetter – volume: 128 start-page: 2158 year: 2011 end-page: 2165 ident: b0140 article-title: Association between melanoma thickness, clinical skin examination and socioeconomic status: results of a large population-based study publication-title: Int J Cancer contributor: fullname: Aitken – volume: 89 start-page: 271 year: 2000 end-page: 279 ident: b0180 article-title: Delays in diagnosis and melanoma prognosis (I): the role of patients publication-title: Int J Cancer contributor: fullname: Avril – volume: 366 start-page: 707 year: 2012 end-page: 714 ident: b0215 article-title: Survival in BRAF V600 – mutant advanced melanoma treated with vemurafenib publication-title: N Engl J Med contributor: fullname: Schuchter – volume: 118 start-page: 3725 year: 2012 end-page: 3734 ident: b0165 article-title: Behavioral determinants of successful early melanoma detection publication-title: Cancer contributor: fullname: Geller – volume: 19 start-page: 475 year: 1984 end-page: 478 ident: b0035 article-title: Risks, survival and trends of malignant melanoma among white and blue collar workers in Sweden publication-title: Soc Sci Med contributor: fullname: Persson – volume: 364 start-page: 2507 year: 2011 end-page: 2516 ident: b0210 article-title: Improved survival with vemurafenib in melanoma with BRAF V600E mutation publication-title: N Engl J Med contributor: fullname: Robert – volume: 86 start-page: 113 year: 2011 end-page: 119 ident: b0050 article-title: Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I–II primary cutaneous melanoma publication-title: Mayo Clin Proc contributor: fullname: Piazzalunga – volume: 83 start-page: 1664 year: 1998 end-page: 1678 ident: b0075 article-title: The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society publication-title: Cancer contributor: fullname: Menck – volume: 19 start-page: 3622 year: 2001 end-page: 3634 ident: b0175 article-title: Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system publication-title: J Clin Oncol contributor: fullname: Gershenwald – volume: 65 start-page: 327 year: 2010 end-page: 333 ident: b0195 article-title: Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden publication-title: Thorax contributor: fullname: Lambe – volume: 24 start-page: 659 year: 2009 end-page: 667 ident: b0090 article-title: The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research publication-title: Eur J Epidemiol contributor: fullname: Ekbom – volume: 145 start-page: 488 year: 2009 end-page: 490 ident: b0160 article-title: Gender differences in melanoma awareness and detection practices between middle-aged and older men with melanoma and their female spouses publication-title: Arch Dermatol contributor: fullname: Geller – volume: 312 start-page: 1125 year: 1996 end-page: 1128 ident: b0080 article-title: Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status publication-title: BMJ contributor: fullname: Hole – volume: 65 start-page: S58.e1 year: 2011 end-page: S58.e12 ident: b0045 article-title: Association of cutaneous melanoma incidence with area-based socioeconomic indicators – United States, 2004–2006 publication-title: J Am Acad Dermatol contributor: fullname: Johnson – volume: 54 start-page: 1758 year: 2006 end-page: 1764 ident: b0065 article-title: Socioeconomic status and survival in older patients with melanoma publication-title: J Am Geriatr Soc contributor: fullname: Kuo – volume: 19 start-page: 156 year: 2008 end-page: 162 ident: b0070 article-title: Influence of education level on cancer survival in Sweden publication-title: Ann Oncol contributor: fullname: Hemminki – volume: 19 start-page: 3635 year: 2001 end-page: 3648 ident: b0115 article-title: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma publication-title: J Clin Oncol contributor: fullname: Soong – volume: 30 start-page: 2240 year: 2012 end-page: 2247 ident: b0155 article-title: Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four european organisation for research and treatment of cancer phase III trials publication-title: J Clin Oncol contributor: fullname: Suciu – volume: 101 start-page: 2067 year: 2004 end-page: 2078 ident: b0095 article-title: Invasive cutaneous malignant melanoma in Sweden, 1990–1999. A prospective, population-based study of survival and prognostic factors publication-title: Cancer contributor: fullname: Dufmats – volume: 363 start-page: 711 year: 2010 end-page: 723 ident: b0205 article-title: Improved survival with ipilimumab in patients with metastatic melanoma publication-title: N Engl J Med contributor: fullname: McDermott – volume: 47 start-page: 1398 year: 2011 end-page: 1406 ident: b0200 article-title: Differences according to educational level in the management and survival of colorectal cancer in Sweden publication-title: Eur J Cancer contributor: fullname: Glimelius – volume: 163 start-page: 1269 year: 2010 end-page: 1275 ident: b0170 article-title: Trends in reported sun bed use, sunburn, and sun care knowledge and attitudes in a U.K. region: results of a survey of the Northern Ireland population publication-title: Br J Dermatol contributor: fullname: Donnelly – volume: 13 start-page: 72 year: 2005 end-page: 74 ident: b0230 article-title: The Swedish Melanoma Study Group – a brief history publication-title: Arch Oncol contributor: fullname: Hansson – volume: 23 start-page: 6054 year: 2005 end-page: 6062 ident: b0190 article-title: Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy publication-title: J Clin Oncol contributor: fullname: Ding – volume: 65 start-page: S17 year: 2011 end-page: S25 ident: b0020 article-title: Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992–2006 publication-title: J Am Acad Dermatol contributor: fullname: Patel – volume: 53 start-page: 457 year: 1958 end-page: 481 ident: b0130 article-title: Nonparametric estimation from incomplete observations publication-title: J Am Stat Assoc contributor: fullname: Meier – volume: 118 start-page: 4004 year: 2012 end-page: 4013 ident: b0245 article-title: Examining the pathways linking lower socioeconomic status and advanced melanoma publication-title: Cancer contributor: fullname: Geller – volume: 156 start-page: 938 year: 2007 end-page: 944 ident: b0145 article-title: Factors associated with a high tumour thickness in patients with melanoma publication-title: Br J Dermatol contributor: fullname: Schmid-Wendtner – volume: 156 start-page: 938 issue: 5 year: 2007 ident: 10.1016/j.ejca.2013.03.013_b0145 article-title: Factors associated with a high tumour thickness in patients with melanoma publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2007.07805.x contributor: fullname: Baumert – ident: 10.1016/j.ejca.2013.03.013_b0015 – volume: 19 start-page: 475 issue: 4 year: 1984 ident: 10.1016/j.ejca.2013.03.013_b0035 article-title: Risks, survival and trends of malignant melanoma among white and blue collar workers in Sweden publication-title: Soc Sci Med doi: 10.1016/0277-9536(84)90207-7 contributor: fullname: Vagero – volume: 103 start-page: 1742 issue: 11 year: 2010 ident: 10.1016/j.ejca.2013.03.013_b0220 article-title: A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605949 contributor: fullname: Louwman – volume: 130 start-page: 170 issue: 1 year: 2012 ident: 10.1016/j.ejca.2013.03.013_b0030 article-title: Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990–2006 publication-title: Int J Cancer doi: 10.1002/ijc.25996 contributor: fullname: Baade – ident: 10.1016/j.ejca.2013.03.013_b0005 – volume: 47 start-page: 1398 issue: 9 year: 2011 ident: 10.1016/j.ejca.2013.03.013_b0200 article-title: Differences according to educational level in the management and survival of colorectal cancer in Sweden publication-title: Eur J Cancer doi: 10.1016/j.ejca.2010.12.013 contributor: fullname: Cavalli-Björkman – volume: 83 start-page: 1664 issue: 8 year: 1998 ident: 10.1016/j.ejca.2013.03.013_b0075 article-title: The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G contributor: fullname: Chang – volume: 364 start-page: 2507 issue: 26 year: 2011 ident: 10.1016/j.ejca.2013.03.013_b0210 article-title: Improved survival with vemurafenib in melanoma with BRAF V600E mutation publication-title: N Engl J Med doi: 10.1056/NEJMoa1103782 contributor: fullname: Chapman – volume: 13 start-page: 72 issue: Suppl. 1 year: 2005 ident: 10.1016/j.ejca.2013.03.013_b0230 article-title: The Swedish Melanoma Study Group – a brief history publication-title: Arch Oncol contributor: fullname: Hansson – volume: 65 start-page: S17 issue: 5 Suppl. 1 year: 2011 ident: 10.1016/j.ejca.2013.03.013_b0020 article-title: Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992–2006 publication-title: J Am Acad Dermatol contributor: fullname: Jemal – volume: 312 start-page: 1125 issue: 7039 year: 1996 ident: 10.1016/j.ejca.2013.03.013_b0080 article-title: Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status publication-title: BMJ doi: 10.1136/bmj.312.7039.1125 contributor: fullname: MacKie – volume: 118 start-page: 3725 issue: 15 year: 2012 ident: 10.1016/j.ejca.2013.03.013_b0165 article-title: Behavioral determinants of successful early melanoma detection publication-title: Cancer doi: 10.1002/cncr.26707 contributor: fullname: Swetter – volume: 19 start-page: 3622 issue: 16 year: 2001 ident: 10.1016/j.ejca.2013.03.013_b0175 article-title: Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system publication-title: J Clin Oncol doi: 10.1200/JCO.2001.19.16.3622 contributor: fullname: Balch – volume: 118 start-page: 4004 issue: 16 year: 2012 ident: 10.1016/j.ejca.2013.03.013_b0245 article-title: Examining the pathways linking lower socioeconomic status and advanced melanoma publication-title: Cancer doi: 10.1002/cncr.26706 contributor: fullname: Pollitt – volume: 86 start-page: 538 issue: 4 year: 1996 ident: 10.1016/j.ejca.2013.03.013_b0085 article-title: Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts publication-title: Am J Public Health doi: 10.2105/AJPH.86.4.538 contributor: fullname: Geller – ident: 10.1016/j.ejca.2013.03.013_b0010 – volume: 163 start-page: 1269 issue: 6 year: 2010 ident: 10.1016/j.ejca.2013.03.013_b0170 article-title: Trends in reported sun bed use, sunburn, and sun care knowledge and attitudes in a U.K. region: results of a survey of the Northern Ireland population publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2010.09977.x contributor: fullname: Boyle – ident: 10.1016/j.ejca.2013.03.013_b0125 – volume: 44 start-page: 2043 issue: 14 year: 2008 ident: 10.1016/j.ejca.2013.03.013_b0040 article-title: Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994–2003 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2008.06.016 contributor: fullname: Birch-Johansen – volume: 129 start-page: 1666 issue: 7 year: 2009 ident: 10.1016/j.ejca.2013.03.013_b0055 article-title: Increasing burden of melanoma in the United States publication-title: J Invest Dermatol doi: 10.1038/jid.2008.423 contributor: fullname: Linos – volume: 101 start-page: 2067 issue: 9 year: 2004 ident: 10.1016/j.ejca.2013.03.013_b0095 article-title: Invasive cutaneous malignant melanoma in Sweden, 1990–1999. A prospective, population-based study of survival and prognostic factors publication-title: Cancer doi: 10.1002/cncr.20602 contributor: fullname: Lindholm – volume: 95 start-page: 91 issue: 1 year: 2006 ident: 10.1016/j.ejca.2013.03.013_b0060 article-title: Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993–2003 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6603216 contributor: fullname: Downing – volume: 35 start-page: 7 issue: 1 year: 2008 ident: 10.1016/j.ejca.2013.03.013_b0135 article-title: California Medicaid enrollment and melanoma stage at diagnosis: a population-based study publication-title: Am J Prev Med doi: 10.1016/j.amepre.2008.03.026 contributor: fullname: Pollitt – volume: 128 start-page: 2158 issue: 9 year: 2011 ident: 10.1016/j.ejca.2013.03.013_b0140 article-title: Association between melanoma thickness, clinical skin examination and socioeconomic status: results of a large population-based study publication-title: Int J Cancer doi: 10.1002/ijc.25540 contributor: fullname: Youl – volume: 23 start-page: 524 issue: 2 year: 2012 ident: 10.1016/j.ejca.2013.03.013_b0240 article-title: Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates publication-title: Ann Oncol doi: 10.1093/annonc/mdr128 contributor: fullname: Hollestein – volume: 65 start-page: 327 issue: 4 year: 2010 ident: 10.1016/j.ejca.2013.03.013_b0195 article-title: Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden publication-title: Thorax doi: 10.1136/thx.2009.125914 contributor: fullname: Berglund – volume: 30 start-page: 2240 issue: 18 year: 2012 ident: 10.1016/j.ejca.2013.03.013_b0155 article-title: Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four european organisation for research and treatment of cancer phase III trials publication-title: J Clin Oncol doi: 10.1200/JCO.2011.38.0584 contributor: fullname: Joosse – volume: 145 start-page: 488 issue: 4 year: 2009 ident: 10.1016/j.ejca.2013.03.013_b0160 article-title: Gender differences in melanoma awareness and detection practices between middle-aged and older men with melanoma and their female spouses publication-title: Arch Dermatol doi: 10.1001/archdermatol.2009.42 contributor: fullname: Swetter – volume: 363 start-page: 711 issue: 8 year: 2010 ident: 10.1016/j.ejca.2013.03.013_b0205 article-title: Improved survival with ipilimumab in patients with metastatic melanoma publication-title: N Engl J Med doi: 10.1056/NEJMoa1003466 contributor: fullname: Hodi – volume: 18 start-page: 2925 issue: 10 year: 2011 ident: 10.1016/j.ejca.2013.03.013_b0185 article-title: Racial differences in survival after surgical treatment for melanoma publication-title: Ann Surg Oncol doi: 10.1245/s10434-011-1706-3 contributor: fullname: Collins – volume: 19 start-page: 3635 issue: 16 year: 2001 ident: 10.1016/j.ejca.2013.03.013_b0115 article-title: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma publication-title: J Clin Oncol doi: 10.1200/JCO.2001.19.16.3635 contributor: fullname: Balch – volume: 19 start-page: 156 issue: 1 year: 2008 ident: 10.1016/j.ejca.2013.03.013_b0070 article-title: Influence of education level on cancer survival in Sweden publication-title: Ann Oncol doi: 10.1093/annonc/mdm413 contributor: fullname: Hussain – ident: 10.1016/j.ejca.2013.03.013_b0110 – volume: 23 start-page: 6054 issue: 25 year: 2005 ident: 10.1016/j.ejca.2013.03.013_b0190 article-title: Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy publication-title: J Clin Oncol doi: 10.1200/JCO.2005.21.360 contributor: fullname: Cormier – volume: 54 start-page: 1758 issue: 11 year: 2006 ident: 10.1016/j.ejca.2013.03.013_b0065 article-title: Socioeconomic status and survival in older patients with melanoma publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2006.00943.x contributor: fullname: Reyes-Ortiz – volume: 53 start-page: 457 issue: 282 year: 1958 ident: 10.1016/j.ejca.2013.03.013_b0130 article-title: Nonparametric estimation from incomplete observations publication-title: J Am Stat Assoc doi: 10.1080/01621459.1958.10501452 contributor: fullname: Kaplan – volume: 86 start-page: 113 issue: 2 year: 2011 ident: 10.1016/j.ejca.2013.03.013_b0050 article-title: Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I–II primary cutaneous melanoma publication-title: Mayo Clin Proc doi: 10.4065/mcp.2010.0671 contributor: fullname: Mandala – volume: 366 start-page: 707 issue: 8 year: 2012 ident: 10.1016/j.ejca.2013.03.013_b0215 article-title: Survival in BRAF V600 – mutant advanced melanoma treated with vemurafenib publication-title: N Engl J Med doi: 10.1056/NEJMoa1112302 contributor: fullname: Sosman – volume: 65 start-page: S58.e1 issue: 5, Suppl. 1 year: 2011 ident: 10.1016/j.ejca.2013.03.013_b0045 article-title: Association of cutaneous melanoma incidence with area-based socioeconomic indicators – United States, 2004–2006 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2011.05.035 contributor: fullname: Singh – volume: 24 start-page: 659 issue: 11 year: 2009 ident: 10.1016/j.ejca.2013.03.013_b0090 article-title: The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research publication-title: Eur J Epidemiol doi: 10.1007/s10654-009-9350-y contributor: fullname: Ludvigsson – volume: 89 start-page: 271 issue: 3 year: 2000 ident: 10.1016/j.ejca.2013.03.013_b0180 article-title: Delays in diagnosis and melanoma prognosis (I): the role of patients publication-title: Int J Cancer doi: 10.1002/1097-0215(20000520)89:3<271::AID-IJC10>3.0.CO;2-7 contributor: fullname: Richard – ident: 10.1016/j.ejca.2013.03.013_b0120 – ident: 10.1016/j.ejca.2013.03.013_b0105 |
SSID | ssj0007840 |
Score | 2.366606 |
Snippet | Abstract Background A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the... A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association between... BACKGROUNDA worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the association... BACKGROUND: A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the... BACKGROUND: A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the... Background: A worse outcome has been reported for cutaneous malignant melanoma (CMM) patients with low socioeconomic status. We have investigated the... |
SourceID | swepub proquest crossref pubmed pascalfrancis elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 2705 |
SubjectTerms | Adult Aged Aged, 80 and over Biological and medical sciences Cancer och onkologi Clinical Medicine diagnosis Educational Status Female Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi Follow-Up Studies Hematology, Oncology and Palliative Medicine Humans Hälsovetenskap Incidence Kaplan-Meier Estimate Kirurgi Klinisk medicin Level of education Logistic Models Male Medical and Health Sciences Medical sciences Medicin och hälsovetenskap Melanoma Melanoma - diagnosis Melanoma - epidemiology Melanoma - surgery Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Neoplasm Staging Outcome Assessment (Health Care) - statistics & numerical data Pharmacology. Drug treatments Population-based Prognosis Proportional Hazards Models Registries - statistics & numerical data Skin - pathology Skin Neoplasms - diagnosis Skin Neoplasms - epidemiology Skin Neoplasms - surgery Social Class Socioeconomic status Stage at Stage at diagnosis Surgery Survival Sweden - epidemiology Tumors |
Title | Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0959804913002165 https://dx.doi.org/10.1016/j.ejca.2013.03.013 https://www.ncbi.nlm.nih.gov/pubmed/23583439 https://search.proquest.com/docview/1399055140 https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-95938 https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-76655 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-204837 https://lup.lub.lu.se/record/3975504 http://kipublications.ki.se/Default.aspx?queryparsed=id:126921342 |
Volume | 49 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELZ6SAgJIW7CURkJeEGhiWMnDm-r0qoc7Usp6tso8VGl7KXNRn3j5_A7mcmxqLBQCSmWIu_YyXomM5_H4zFjL4W2Nk1sGqbe-1Dq1IRaFlHoM7TONpZx4WiD89FxengqP56psw22N-yFobDKXvd3Or3V1n3Nbj-au_Oq2j0hD5ZGgEsLMiJO1SbbbheJttj26MOnw-OVQs50uy-y83hhg37vTBfm5S4MpR-KkzbXaZz8zT7dmhc1jprvjrtYh0d_SzbaGqiDO-x2jyz5qHv5u2zDTe-xG0f92vl99uPz7JKPKUaIzzx3Q2AHr2pe9DxylpNflo_xdsERN547Xiy57cLxiHBq-YKaImXdoJZBOeXVlJsGMaabNTWfIK4_p-AaPnHjYjqbFO_4iHcux8vKOj5fnRgWkgXFfijBLXVyculQCT5gpwf7X_YOw_6UhtBkUb4MtRE0zZWRNSbROH2Ltfd5ap2KpHTKapFrqickZUqvXYn2MStKJ4sspkXUh2xrOpu6x4yL3CD_clMockwqkZeS4FwmVYE4NMkD9mbgDcy7ZBwwRKldAHESiJMQ4RUnAcsG9sGwzRQVo6v7r7SGGGoBEfwhSQFTq5ZXhBHQzvzziTtXpGT1kiJTKpE6CtiLQWwAP2Nam-m4AwjE84jQK9I86uTpV-tE4fjS33_VCdjqF8oN_r76OoLZ4hzGVQOUZlpfQ9dMGsjSVKnr6BoQ7YEDAdtfQzdu5lhKLFA7kN6lskxKSAobgcSJAmivJZi49In1wsjUBEys6YeAAvT13yoq1F8s0pySDYqAvV7TaEVPtAqNVCKf_CfTnrKboj3ihNxqz9jWctG45wg0l-UO23z7Pd7p1clPLrqByQ |
link.rule.ids | 230,315,783,787,888,4033,4511,24130,27937,27938,27939,45599,45693 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELZKKwESQtyEoxgJeEFRE8dOHN5W0GpLj5e2qG-jxEeVspc2G_Uf8TuZ2SSLCguVkGIp8o6drGcy83k8HjP2Tmhr08SmYeq9D6VOTahlEYU-Q-tsYxkXjjY4Hx2nwzP59Vydb7DP_V4YCqvsdH-r05fauqvZ6UZzZ1ZVOyfkwdIIcGlBRsSpusW2EA3kKOxbg_2D4fFKIWd6uS-y9Xhhg27vTBvm5S4NpR-Kk2Wu0zj5m326NytqHDXfHnexDo_-lmx0aaD2HrD7HbLkg_blH7INN3nEbh91a-eP2Y_D6RUfUYwQn3ru-sAOXtW86HjkLCe_LB_h7ZwjbrxwvFhw24bjEeHE8jk1Rcq6QS2DcsqrCTcNYkw3bWo-Rlx_QcE1fOxGxWQ6Lj7xAW9djleVdXy2OjEsJAuK_VCCW-rk5MqhEnzCzvZ2Tz8Pw-6UhtBkUb4ItRE0zZWRNSbROH2Ltfd5ap2KpHTKapFrqickZUqvXYn2MStKJ4sspkXUp2xzMp2454yL3CAzc1MockwqkZeS4FwmVYE4NMkD9rHnDczaZBzQR6ldAnESiJMQ4RUnAct69kG_zRQVo6u7r7SGGGoBEfwhSQFTq5bXhBHQzvzzidvXpGT1kiJTKpE6CtjbXmwAP2Nam2m5AwjE84jQK9I8a-XpV-tE4fjS33_fCtjqF8oN_qX6NoDp_AJGVQOUZlrfQNeMG8jSVKmb6BoQywMHAra7hm7UzLCUWKB2IL1LZZmUkBQ2AokTBdBeSzBx6RPrhZGpCZhY0w8BBejqv1dUqL9YpDklGxQB-7Cm0YqeaBUaqUS--E-mvWF3hqdHh3C4f3zwkt0Vy-NOyMX2im0u5o17jaBzUW53SuUnnSmDxg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Low+level+of+education+is+associated+with+later+stage+at+diagnosis+and+reduced+survival+in+cutaneous+malignant+melanoma&rft.jtitle=European+journal+of+cancer+%281990%29&rft.au=Eriksson%2C+H.&rft.au=Lyth%2C+J.&rft.au=Mansson-Brahme%2C+E.&rft.au=Frohm-Nilsson%2C+M.&rft.date=2013&rft.issn=0959-8049&rft.volume=49&rft.issue=12&rft.spage=2705&rft_id=info:doi/10.1016%2Fj.ejca.2013.03.013&rft.externalDocID=oai_DiVA_org_uu_204837 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09598049%2FS0959804913X00103%2Fcov150h.gif |